Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 344

1.

Combination of sunitinib and PD-L1 blockade enhances anticancer efficacy of TLR7/8 agonist-based nanovaccine.

Kim H, Khanna V, Kucaba TA, Zhang W, Ferguson DM, Griffith TS, Panyam J.

Mol Pharm. 2019 Jan 8. doi: 10.1021/acs.molpharmaceut.8b01165. [Epub ahead of print]

PMID:
30620878
2.

poly(D,L-lactide-co-glycolide) nanoparticles as a vaccine delivery platform for TLR7/8 agonist-based cancer vaccine.

Kim H, Griffith T, Panyam J.

J Pharmacol Exp Ther. 2019 Jan 4. pii: jpet.118.254953. doi: 10.1124/jpet.118.254953. [Epub ahead of print]

3.

Polymicrobial Sepsis Chronic Immunoparalysis Is Defined by Diminished Ag-Specific T Cell-Dependent B Cell Responses.

Sjaastad FV, Condotta SA, Kotov JA, Pape KA, Dail C, Danahy DB, Kucaba TA, Tygrett LT, Murphy KA, Cabrera-Perez J, Waldschmidt TJ, Badovinac VP, Griffith TS.

Front Immunol. 2018 Oct 31;9:2532. doi: 10.3389/fimmu.2018.02532. eCollection 2018.

4.

Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade.

Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR, Grossenbacher SK, Withers SS, Rebhun RB, Hartigan-O'Connor DJ, Méndez-Lagares G, Tarantal AF, Isseroff RR, Griffith TS, Schalper KA, Merleev A, Saha A, Maverakis E, Kelly K, Aljumaily R, Ibrahimi S, Mukherjee S, Machiorlatti M, Vesely SK, Longo DL, Blazar BR, Canter RJ, Murphy WJ, Monjazeb AM.

Nat Med. 2019 Jan;25(1):141-151. doi: 10.1038/s41591-018-0221-5. Epub 2018 Nov 12.

PMID:
30420753
5.

Merkel Cells Activate Sensory Neural Pathways through Adrenergic Synapses.

Hoffman BU, Baba Y, Griffith TN, Mosharov EV, Woo SH, Roybal DD, Karsenty G, Patapoutian A, Sulzer D, Lumpkin EA.

Neuron. 2018 Dec 19;100(6):1401-1413.e6. doi: 10.1016/j.neuron.2018.10.034. Epub 2018 Nov 8.

PMID:
30415995
6.

Acidic pH-responsive polymer nanoparticles as a TLR7/8 agonist delivery platform for cancer immunotherapy.

Kim H, Sehgal D, Kucaba TA, Ferguson DM, Griffith TS, Panyam J.

Nanoscale. 2018 Nov 15;10(44):20851-20862. doi: 10.1039/c8nr07201a.

PMID:
30403212
7.

Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections.

Jensen IJ, Winborn CS, Fosdick MG, Shao P, Tremblay MM, Shan Q, Tripathy SK, Snyder CM, Xue HH, Griffith TS, Houtman JC, Badovinac VP.

PLoS Pathog. 2018 Oct 31;14(10):e1007405. doi: 10.1371/journal.ppat.1007405. eCollection 2018 Oct.

8.

Challenges of Medical Care Delivery in Professional Sports: Lessons From Professional Baseball.

Duralde X, Jones T, Griffith T.

J Am Acad Orthop Surg. 2018 Dec 15;26(24):872-880. doi: 10.5435/JAAOS-D-17-00430.

PMID:
30285985
9.

Cutting Edge: Elevated Leptin during Diet-Induced Obesity Reduces the Efficacy of Tumor Immunotherapy.

Murphy KA, James BR, Sjaastad FV, Kucaba TA, Kim H, Brincks EL, Chua SC Jr, Wilber A, Griffith TS.

J Immunol. 2018 Oct 1;201(7):1837-1841. doi: 10.4049/jimmunol.1701738. Epub 2018 Aug 22.

PMID:
30135180
10.

Relationship Between Duration of Tube Feeding and Success of Oral Feeding in Preterm Infants.

Griffith TT, Bell AF, White-Traut R, Medoff-Cooper B, Rankin K.

J Obstet Gynecol Neonatal Nurs. 2018 Sep;47(5):620-631. doi: 10.1016/j.jogn.2018.06.002. Epub 2018 Jul 21.

PMID:
30040913
11.

Oral Feeding Success: A Concept Analysis.

Griffith TT, Bell AF, Vincent C, White-Traut R, Medoff-Cooper B, Rankin K.

Adv Neonatal Care. 2018 Jul 19. doi: 10.1097/ANC.0000000000000540. [Epub ahead of print]

PMID:
30028735
12.

Eradication of Established Tumors by Chemically Self-Assembled Nanoring Labeled T Cells.

Petersburg JR, Shen J, Csizmar CM, Murphy KA, Spanier J, Gabrielse K, Griffith TS, Fife B, Wagner CR.

ACS Nano. 2018 Jul 24;12(7):6563-6576. doi: 10.1021/acsnano.8b01308. Epub 2018 Jun 4.

PMID:
29792808
13.

HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetes.

Tasyurek HM, Eksi YE, Sanlioglu AD, Altunbas HA, Balci MK, Griffith TS, Sanlioglu S.

Gene Ther. 2018 Jul;25(4):269-283. doi: 10.1038/s41434-018-0011-1. Epub 2018 Mar 9.

PMID:
29523882
14.

Imaging in Congenital and Hereditary Abnormalities of the Interventricular Septum: Clinical Anatomy and Diagnostic Clues.

Kim AM, Hunter TA, McQuillan BF, Franco DF, Griffith TP, Carter BW, Lichtenberger JP 3rd.

J Thorac Imaging. 2018 May;33(3):147-155. doi: 10.1097/RTI.0000000000000326. Review.

PMID:
29489583
15.

Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy.

Kim H, Niu L, Larson P, Kucaba TA, Murphy KA, James BR, Ferguson DM, Griffith TS, Panyam J.

Biomaterials. 2018 May;164:38-53. doi: 10.1016/j.biomaterials.2018.02.034. Epub 2018 Feb 17.

PMID:
29482062
16.

Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity.

Jensen IJ, Sjaastad FV, Griffith TS, Badovinac VP.

J Immunol. 2018 Mar 1;200(5):1543-1553. doi: 10.4049/jimmunol.1701618. Review.

PMID:
29463691
17.

Elbow Injuries in the Adolescent Thrower.

Griffith TB, Kercher J, Clifton Willimon S, Perkins C, Duralde XA.

Curr Rev Musculoskelet Med. 2018 Mar;11(1):35-47. doi: 10.1007/s12178-018-9457-4. Review.

18.

Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 Gene Therapy for Diabetes.

Tasyurek HM, Altunbas HA, Balci MK, Griffith TS, Sanlioglu S.

Hum Gene Ther. 2018 Jul;29(7):802-815. doi: 10.1089/hum.2017.180. Epub 2018 Mar 20.

PMID:
29409356
19.

The current status of immunobased therapies for metastatic renal-cell carcinoma.

Sathianathen NJ, Krishna S, Anderson JK, Weight CJ, Gupta S, Konety BR, Griffith TS.

Immunotargets Ther. 2017 Dec 5;6:83-93. doi: 10.2147/ITT.S134850. eCollection 2017. Review.

20.

Design and Synthesis of N1-Modified Imidazoquinoline Agonists for Selective Activation of Toll-like Receptors 7 and 8.

Larson P, Kucaba TA, Xiong Z, Olin M, Griffith TS, Ferguson DM.

ACS Med Chem Lett. 2017 Oct 16;8(11):1148-1152. doi: 10.1021/acsmedchemlett.7b00256. eCollection 2017 Nov 9.

21.

TRAIL Deletion Prevents Liver, but Not Adipose Tissue, Inflammation during Murine Diet-Induced Obesity.

Hirsova P, Weng P, Salim W, Bronk SF, Griffith TS, Ibrahim SH, Gores GJ.

Hepatol Commun. 2017 Sep;1(7):648-662. doi: 10.1002/hep4.1069. Epub 2017 Jul 20.

22.

The synergy between ionizing radiation and immunotherapy in the treatment of prostate cancer.

Sathianathen NJ, Krishna S, Konety BR, Griffith TS.

Immunotherapy. 2017 Sep;9(12):1005-1018. doi: 10.2217/imt-2017-0051.

PMID:
28971750
23.

Polymicrobial sepsis impairs bystander recruitment of effector cells to infected skin despite optimal sensing and alarming function of skin resident memory CD8 T cells.

Danahy DB, Anthony SM, Jensen IJ, Hartwig SM, Shan Q, Xue HH, Harty JT, Griffith TS, Badovinac VP.

PLoS Pathog. 2017 Sep 14;13(9):e1006569. doi: 10.1371/journal.ppat.1006569. eCollection 2017 Sep.

24.

Predictive validity of HCR-20, START, and static-99R assessments in predicting institutional aggression among sexual offenders.

Cartwright JK, Desmarais SL, Hazel J, Griffith T, Azizian A.

Law Hum Behav. 2018 Feb;42(1):13-25. doi: 10.1037/lhb0000263. Epub 2017 Aug 31.

PMID:
28857580
25.

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies.

Murphy KA, James BR, Wilber A, Griffith TS.

J Vis Exp. 2017 Apr 12;(122). doi: 10.3791/55080.

26.

Do orally-directed behaviors mediate the relationship between behavioral state and nutritive sucking in preterm infants?

White-Traut R, Liu L, Norr K, Rankin K, Campbell SK, Griffith T, Vasa R, Geraldo V, Medoff-Cooper B.

Early Hum Dev. 2017 Jun;109:26-31. doi: 10.1016/j.earlhumdev.2017.04.007. Epub 2017 Apr 18. No abstract available.

27.

Temperament as a Predictor of Nitrous Oxide Inhalation Sedation Success.

Nelson TM, Griffith TM, Lane KJ, Thikkurissy S, Scott JM.

Anesth Prog. 2017 Spring;64(1):17-21. doi: 10.2344/anpr-63-03-01.

28.

Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.

Guicciardi ME, Krishnan A, Bronk SF, Hirsova P, Griffith TS, Gores GJ.

Cell Death Dis. 2017 Jan 5;8(1):e2535. doi: 10.1038/cddis.2016.459.

29.

Polymicrobial Sepsis Diminishes Dendritic Cell Numbers and Function Directly Contributing to Impaired Primary CD8 T Cell Responses In Vivo.

Strother RK, Danahy DB, Kotov DI, Kucaba TA, Zacharias ZR, Griffith TS, Legge KL, Badovinac VP.

J Immunol. 2016 Dec 1;197(11):4301-4311. Epub 2016 Oct 26.

30.

The Relationship Between Behavioral States and Oral Feeding Efficiency in Preterm Infants.

Griffith T, Rankin K, White-Traut R.

Adv Neonatal Care. 2017 Feb;17(1):E12-E19. doi: 10.1097/ANC.0000000000000318.

31.

Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease.

Cabrera-Perez J, Badovinac VP, Griffith TS.

Exp Biol Med (Maywood). 2017 Jan;242(2):127-139. doi: 10.1177/1535370216669610. Epub 2016 Oct 4. Review.

32.

Clinical and Experimental Sepsis Impairs CD8 T-Cell-Mediated Immunity.

Danahy DB, Strother RK, Badovinac VP, Griffith TS.

Crit Rev Immunol. 2016;36(1):57-74. doi: 10.1615/CritRevImmunol.2016017098. Review.

33.

CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas.

Murphy KA, Griffith TS.

Cancers (Basel). 2016 Jul 27;8(8). pii: E71. doi: 10.3390/cancers8080071. Review.

34.

Gut Microbial Membership Modulates CD4 T Cell Reconstitution and Function after Sepsis.

Cabrera-Perez J, Babcock JC, Dileepan T, Murphy KA, Kucaba TA, Badovinac VP, Griffith TS.

J Immunol. 2016 Sep 1;197(5):1692-8. doi: 10.4049/jimmunol.1600940. Epub 2016 Jul 22.

35.

Control of Ca2+ Influx and Calmodulin Activation by SK-Channels in Dendritic Spines.

Griffith T, Tsaneva-Atanasova K, Mellor JR.

PLoS Comput Biol. 2016 May 27;12(5):e1004949. doi: 10.1371/journal.pcbi.1004949. eCollection 2016 May.

36.

Service Learning.

Griffith T, Clark KR.

Radiol Technol. 2016 May;87(5):586-8. No abstract available.

PMID:
27146187
37.

Distribution of Force in the Medial Collateral Ligament Complex During Simulated Clinical Tests of Knee Stability.

Schafer KA, Tucker S, Griffith T, Sheikh S, Wickiewicz TL, Nawabi DH, Imhauser CW, Pearle AD.

Am J Sports Med. 2016 May;44(5):1203-8. doi: 10.1177/0363546515623510. Epub 2016 Jan 25.

PMID:
26811305
38.

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms.

Di Bartolo BA, Cartland SP, Prado-Lourenco L, Griffith TS, Gentile C, Ravindran J, Azahri NS, Thai T, Yeung AW, Thomas SR, Kavurma MM.

J Am Heart Assoc. 2015 Nov 16;4(11). pii: e002527. doi: 10.1161/JAHA.115.002527.

39.

Glenoid Bone-Grafting in Revision to a Reverse Total Shoulder Arthroplasty.

Wagner E, Houdek MT, Griffith T, Elhassan BT, Sanchez-Sotelo J, Sperling JW, Cofield RH.

J Bone Joint Surg Am. 2015 Oct 21;97(20):1653-60. doi: 10.2106/JBJS.N.00732.

PMID:
26491129
40.

Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma.

Brincks EL, Kucaba TA, James BR, Murphy KA, Schwertfeger KL, Sangwan V, Banerjee S, Saluja AK, Griffith TS.

FEBS J. 2015 Dec;282(24):4747-4765. doi: 10.1111/febs.13532. Epub 2015 Oct 18.

41.

Therapeutic applications of TRAIL receptor agonists in cancer and beyond.

Amarante-Mendes GP, Griffith TS.

Pharmacol Ther. 2015 Nov;155:117-31. doi: 10.1016/j.pharmthera.2015.09.001. Epub 2015 Sep 5. Review.

42.

Identification of critical functional determinants of kainate receptor modulation by auxiliary protein Neto2.

Griffith TN, Swanson GT.

J Physiol. 2015 Nov 15;593(22):4815-33. doi: 10.1113/JP271103. Epub 2015 Sep 20.

43.

Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma.

Murphy KA, James BR, Guan Y, Torry DS, Wilber A, Griffith TS.

Hum Vaccin Immunother. 2015;11(7):1612-20. doi: 10.1080/21645515.2015.1035849.

44.

Polymicrobial Sepsis Increases Susceptibility to Chronic Viral Infection and Exacerbates CD8+ T Cell Exhaustion.

Condotta SA, Khan SH, Rai D, Griffith TS, Badovinac VP.

J Immunol. 2015 Jul 1;195(1):116-25. doi: 10.4049/jimmunol.1402473. Epub 2015 May 15.

45.

The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse.

Laudenbach M, Baruffaldi F, Vervacke JS, Distefano MD, Titcombe PJ, Mueller DL, Tubo NJ, Griffith TS, Pravetoni M.

J Immunol. 2015 Jun 15;194(12):5926-36. doi: 10.4049/jimmunol.1500385. Epub 2015 May 13.

46.

Adjunctive intraventricular antibiotic therapy for bacterial central nervous system infections in critically ill patients with traumatic brain injury.

McClellan N, Swanson JM, Magnotti LJ, Griffith TW, Wood GC, Croce MA, Boucher BA, Mueller EW, Fabian TC.

Ann Pharmacother. 2015 May;49(5):515-22. doi: 10.1177/1060028015570466. Epub 2015 Feb 17.

PMID:
25690904
47.

Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge.

Cabrera-Perez J, Condotta SA, James BR, Kashem SW, Brincks EL, Rai D, Kucaba TA, Badovinac VP, Griffith TS.

J Immunol. 2015 Feb 15;194(4):1609-20. doi: 10.4049/jimmunol.1401711. Epub 2015 Jan 16.

48.

Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naïve T-cells but no enduring cell-autonomous defects in T-cell function.

Markwart R, Condotta SA, Requardt RP, Borken F, Schubert K, Weigel C, Bauer M, Griffith TS, Förster M, Brunkhorst FM, Badovinac VP, Rubio I.

PLoS One. 2014 Dec 26;9(12):e115094. doi: 10.1371/journal.pone.0115094. eCollection 2014.

49.

Competitive replacement of invasive congeners may relax impact on native species: interactions among zebra, quagga, and native unionid mussels.

Burlakova LE, Tulumello BL, Karatayev AY, Krebs RA, Schloesser DW, Paterson WL, Griffith TA, Scott MW, Crail T, Zanatta DT.

PLoS One. 2014 Dec 9;9(12):e114926. doi: 10.1371/journal.pone.0114926. eCollection 2014.

50.

CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma.

James BR, Anderson KG, Brincks EL, Kucaba TA, Norian LA, Masopust D, Griffith TS.

Cancer Immunol Immunother. 2014 Nov;63(11):1213-27. doi: 10.1007/s00262-014-1598-8. Epub 2014 Aug 21.

Supplemental Content

Loading ...
Support Center